APA (7th ed.) Citation

Liu, X., Zhang, T., Fu, R., Liu, D., Zhang, J., Hu, Q., . . . Ren, L. (2025). Exploring the effect of dapagliflozin on coronary inflammation in type 2 diabetes patients based on the coronary artery perivascular fat attenuation index. Cardiovascular Diabetology, 24(1), 1. https://doi.org/10.1186/s12933-025-02723-7

Chicago Style (17th ed.) Citation

Liu, Xuehua, Tian Zhang, Rong Fu, Dan Liu, Jingyi Zhang, Qing Hu, Guangyao Song, and Luping Ren. "Exploring the Effect of Dapagliflozin on Coronary Inflammation in Type 2 Diabetes Patients Based on the Coronary Artery Perivascular Fat Attenuation Index." Cardiovascular Diabetology 24, no. 1 (2025): 1. https://doi.org/10.1186/s12933-025-02723-7.

MLA (9th ed.) Citation

Liu, Xuehua, et al. "Exploring the Effect of Dapagliflozin on Coronary Inflammation in Type 2 Diabetes Patients Based on the Coronary Artery Perivascular Fat Attenuation Index." Cardiovascular Diabetology, vol. 24, no. 1, 2025, p. 1, https://doi.org/10.1186/s12933-025-02723-7.